Trading IdeasFundamentals

Tejnaksh Healthcare Limited

BSE: TEJNAKSH · Healthcare Service Provider · sector

₹12.67BSE close 2026-10-26

Key numbers

Market cap₹26 cr
Price₹12.67
52w high / low₹19 / ₹11
P/E21.5xSector median 22.9x
P/B0.9xSector median 2.0x
Book value₹13.4
Dividend yield–Sector median 0.55%
ROE4.7%Sector median 5.4%
ROCE6.8%Sector median 6.8%
OPM26.5%Sector median 15.9%
Debt / equity0.00xSector median 0.07x
EV/EBITDA8.3xSector median 17.2x
Interest cover33.9x
Current ratio8.45x
Sales growth 3y+13.7%Sector median +13.5%
Profit growth 3y-3.8%Sector median +26.9%
PEG–

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹28.30 · low ₹12.00
Sep 2024Apr 2025Oct 2025Apr 2026

Quarterly results

₹ crMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue333333
EBITDA111111
OPM %22.1%22.7%25.8%26.3%27.8%26.0%
Other income000000
Net profit100000
EPS (₹)0.210.120.150.140.170.13
Revenue YoY-20.6%+0.4%
Profit YoY-29.4%+8.0%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ crFY22FY23FY24FY25FY26TTM
Revenue878131111
EBITDA434433
Net profit312211
EPS (₹)2.481.360.891.150.610.59
Revenue growth-9.6%+12.0%+56.9%-16.4%–
Profit growth-45.2%+31.2%+28.7%-47.2%–
Dividend / share (₹)–––––
Compounded growth3 years5 yearsLast 12 months
Sales+13.7%––
Net profit-3.8%––
EPS-23.5%––
Share price–-30.5% (2y)-35.7%

Balance sheet

₹ crFY25FY26
Shareholders' equity2627
Borrowings10
Cash & equivalents22
Total assets3030
Fixed assets1918
Capital work in progress–0
Investments00
Receivables22
Inventory11
Payables00

Year-end figures from the March annual filing.

Cash flow

₹ crFY25FY26
Cash from operations02
Cash from investing4-0
Cash from financing-4-1
Capex11
Free cash flow-01

Free cash flow = cash from operations − capex.

Ratios by year

₹ crFY25FY26
ROE %9.0%4.5%
ROCE %13.4%6.4%
Debtor days5274
Inventory days224298
Payable days8586
Cash conversion cycle (days)191286
Working capital days137158

Peers in Healthcare Service Provider

CompanyMarket capP/EP/BROEROCEOPMSales 3yDiv yield
LALPATHLAB₹31,100 cr57.2x12.4x23.1%29.6%27.9%+11.1%0.71%
VIJAYA₹14,362 cr76.6x15.0x21.4%30.1%42.2%+21.0%0.14%
METROPOLIS₹10,989 cr54.5x7.3x14.2%19.7%24.2%+12.8%0.19%
THYROCARE₹7,491 cr42.6x12.8x31.1%39.7%31.4%+16.3%1.99%
NEPHROPLUS₹6,095 cr71.6x5.5x6.9%13.4%22.7%––
SURAKSHA₹1,628 cr45.4x6.7x15.7%25.2%31.4%––
KRSNAA₹1,617 cr16.6x1.6x10.5%11.1%26.8%+16.6%0.55%
3BBLACKBIO₹1,193 cr21.2x3.7x18.7%22.8%34.9%+127.8%0.29%
HEALTHX₹857 cr–3.2x-0.5%––––
TEJNAKSH₹26 cr21.5x0.9x4.7%6.8%26.5%+13.7%–

All 31 companies in Healthcare Service Provider →

Documents

Links go to the original files on the exchange website.

About the company

SectorHealthcare
IndustryHealthcare Service Provider
Sub-industryHealthcare Service Provider
SymbolTEJNAKSH
BSE code539428
ISININE030T01027
Face value₹5.0
Incorporated–
Website–
Plants (India / abroad)–

Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.